Anwerina Deutschland Overview
- Founded
-
2009
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Corporate
- Financing Rounds
-
1
Anwerina Deutschland General Information
Description
Developer and manufacturer of pharmaceutical products intended to improve the quality of life of patients with diseases or trauma to the musculoskeletal system. The company develops and manufactures pharmaceutical products with a focus on metabolic bone diseases.
Contact Information
Website
www.anwerina.com
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Primary Office
- Reichskanzler-Müller-Straße 21
- 68165 Mannheim
- Germany
+49 0621 00000000
Anwerina Deutschland Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Anwerina Deutschland Patents
Anwerina Deutschland Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| DE-102021110029-A1 | Process for manufacturing a monolithic component | Pending | 21-Apr-2021 | 0000000000 | 0 |
Anwerina Deutschland Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Christoph Karl | Managing Director | ||
| Michaela Werner | Managing Director |
Anwerina Deutschland Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Anwerina Deutschland Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|